What does Relyvrio's recent EMA rejection mean for ALS patients in Europe? All you need to know (and what you can do to get the treatment quickly)
Blog
-
February 13, 2024
-
February 13, 2024
When will Radicut/Radicava(edaravone) be available to ALS patients in Europe and the UK (and what to do in the meantime).
-
February 06, 2024
When is the first nasal spray for dry eyes coming to Europe (and what to do in the meantime)
-
February 06, 2024
Topical roflumilast isn't likely to be available in Europe soon. Here's what you can expect, and some solutions for the meantime.
-
January 31, 2024
How effective is adagrasib for brain metastases? The latest data, and how to access the treatment quickly.
-
January 23, 2024
When are Elahere's EMA and MHRA approvals expected, and what can patients in Europe and the UK do in the meantime.
-
January 23, 2024
When will Leqembi receive MHRA approval? And how you can access the medicine in the meantime.
-
January 15, 2024
Ryzneuta's EMA and MHRA approvals seem nowhere in sight. Here's how you can access the medicine without waiting.
-
January 15, 2024
When will capivasertib be available to breast cancer patients in Europe and the UK? Approval status, timelines, and all your options for accessing the medicine quickly.
-
January 15, 2024
Everything you need to know about nitrogacestat's approval in Europe and the UK. Including all your options to access the medicine earlier.
-
January 08, 2024
What's after Enhertu? Some of the alternatives your doctor may consider if Enhertu starts working.
-
December 12, 2023
How does Herceptin compare to Enhertu? Find out the similarities and differences between these two treatments for HER2-positive cancer.
-
December 12, 2023
What is the age limit for ruxolitinib? Find out all about the potential use of Opzelura on children.
-
December 06, 2023
When is margetuximab's EMA and MHRA approval expected? And what are your options in the meantime?
-
December 06, 2023
Is reportrectinib getting EMA approval soon, and how can you access it in the meantime?
-
December 06, 2023
How effective is fruquintinib for lung cancer? The latest clinical trial results, and what they could mean for your treatment.
-
December 04, 2023
What is the fastest migraine relief medicine that you can get in Europe and the UK in 2023?
-
November 21, 2023
When can colorectal cancer patients in Europe and the UK expect to have access to Fruzaqla?
-
November 20, 2023
When will Ojjaara be available to myelofibrosis patients in Europe and the UK? And what you can do in the meantime.
-
November 13, 2023
What patients in Europe and the UK need to know about vamorolone's availability timeline.
-
November 13, 2023
When will Zavegepant be available in the UK (and what to do in the meantime)
-
November 06, 2023
Where is Enhertu approved for the treatment of advanced NSCLC, and how can you access it?
-
October 30, 2023
How to safely access Ozempic in Australia until the medicine shortage is resolved.
-
October 30, 2023
How to safely access Ozempic in the UK until the medicine shortage is resolved.
-
October 30, 2023
How effective is Enhertu for colorectal cancer? Find out the latest trial results and what they can mean for your treatment.
-
October 17, 2023
Inclisiran could play a role in preventing cardiovascular events. Find out all about its availability in the UK, and what it can mean for you.
-
October 17, 2023
Pirtobrutinib is not yet approved and available in the EU and UK. But doesn't mean you can't access it immediately. Read on for all your options.
-
October 16, 2023
Belzutifan is currently approved as an orphan medicine in the UK. Find out when it will be widely available on the market, and what that means for you.
-
October 10, 2023
Everything you should know about Enhertu in the UK. What is it approved for, and how can you access it?
-
October 03, 2023
How effective is Enhertu for ovarian cancer, and can your doctor prescribe it before it's approved for this indication? All the answers - here.